Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole for Respiratory Function in SCI with GERD
NCT02584751Phase 1Unknown
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Aug 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of omeprazole in gastroesophageal reflux disease (GERD) (4 arms), sponsored by James J. Peters Veterans Affairs Medical Center. Primary endpoint: DeMeester Score at 24 hours. Status: unknown.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02584751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584751.